<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00537810</url>
  </required_header>
  <id_info>
    <org_study_id>0501027352</org_study_id>
    <secondary_id>R01DK073542-01A1</secondary_id>
    <nct_id>NCT00537810</nct_id>
  </id_info>
  <brief_title>Treatment of Binge Eating in Obese Patients in Primary Care</brief_title>
  <official_title>Treatment of Binge Eating in Obese Patients in Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the effectiveness of two empirically-supported but distinct treatments
      for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure
      self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy
      for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered
      alone and in combination in a primary care setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Binge Eating (Remission)</measure>
    <time_frame>4 months treatment; 6 and 12 month follow up post treatment</time_frame>
    <description>Remission from binge eating (zero binge episodes during previous 28 days)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BMI</measure>
    <time_frame>4 months treatment</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Obesity</condition>
  <condition>Binge Eating</condition>
  <arm_group>
    <arm_group_label>Sibutramine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sibutramine 15 mg daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo/CBTsh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo and Self-help CBT Placebo daily, Cognitive behavioral self-help manual for binge eating</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sibutramine/CBTsh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sibutramine and Self-help CBT 15 mg daily Cognitive behavioral treatment manual for binge eating</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sibutramine</intervention_name>
    <description>15 mg daily</description>
    <arm_group_label>Sibutramine</arm_group_label>
    <other_name>Meridia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-help CBT + Sibutramine</intervention_name>
    <description>Cognitive behavioral treatment manual for binge eating Sibutramine 15 mg daily</description>
    <arm_group_label>Placebo/CBTsh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-help CBT + Placebo</intervention_name>
    <description>Cognitive behavioral treatment manual for binge eating Placebo daily</description>
    <arm_group_label>Sibutramine/CBTsh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese (BMI &gt;= 30)

        Exclusion Criteria:

          -  Medication regimen that represents medical contraindication to sibutramine

          -  Serious unstable or uncontrolled medical conditions that represent contraindication to
             sibutramine

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos M. Grilo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale Internal Medicine Associates (YIMA)</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale-New Haven Hospital (YNHH) Primary Care Center (PCC)</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale Psychiatric Research at Congress Place</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Grilo CM, Masheb RM, White MA, Gueorguieva R, Barnes RD, Walsh BT, McKenzie KC, Genao I, Garcia R. Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: randomized placebo-controlled clinical trial of self-help and medication. Behav Res Ther. 2014 Jul;58:1-9. doi: 10.1016/j.brat.2014.04.002. Epub 2014 May 2.</citation>
    <PMID>24857821</PMID>
  </results_reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2007</study_first_submitted>
  <study_first_submitted_qc>September 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2007</study_first_posted>
  <results_first_submitted>June 19, 2014</results_first_submitted>
  <results_first_submitted_qc>December 11, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 12, 2014</results_first_posted>
  <last_update_submitted>December 11, 2014</last_update_submitted>
  <last_update_submitted_qc>December 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Carlos Grilo</investigator_full_name>
    <investigator_title>Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Binge eating</keyword>
  <keyword>Sibutramine</keyword>
  <keyword>Self-help</keyword>
  <keyword>Primary care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Binge-Eating Disorder</mesh_term>
    <mesh_term>Bulimia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sibutramine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sibutramine</title>
          <description>Sibutramine 15 mg daily
Sibutramine: 15 mg daily</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo Daily
Placebo: Daily</description>
        </group>
        <group group_id="P3">
          <title>Placebo/CBTsh</title>
          <description>Placebo and Self-help CBT Placebo daily, Cognitive behavioral self-help manual for binge eating
Self-help CBT + Sibutramine: Cognitive behavioral treatment manual for binge eating Sibutramine 15 mg daily</description>
        </group>
        <group group_id="P4">
          <title>Sibutramine/CBTsh</title>
          <description>Sibutramine and Self-help CBT 15 mg daily Cognitive behavioral treatment manual for binge eating
Self-help CBT + Placebo: Cognitive behavioral treatment manual for binge eating Placebo daily</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="21"/>
                <participants group_id="P4" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Medically withdrawn</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sibutramine</title>
          <description>Sibutramine 15 mg daily
Sibutramine: 15 mg daily</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo Daily
Placebo: Daily</description>
        </group>
        <group group_id="B3">
          <title>Placebo/CBTsh</title>
          <description>Placebo and Self-help CBT Placebo daily, Cognitive behavioral self-help manual for binge eating
Self-help CBT + Sibutramine: Cognitive behavioral treatment manual for binge eating Sibutramine 15 mg daily</description>
        </group>
        <group group_id="B4">
          <title>Sibutramine/CBTsh</title>
          <description>Sibutramine and Self-help CBT 15 mg daily Cognitive behavioral treatment manual for binge eating
Self-help CBT + Placebo: Cognitive behavioral treatment manual for binge eating Placebo daily</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="26"/>
            <count group_id="B5" value="104"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.2" spread="10.3"/>
                    <measurement group_id="B2" value="43.2" spread="12.4"/>
                    <measurement group_id="B3" value="45.7" spread="12.4"/>
                    <measurement group_id="B4" value="45.6" spread="9.4"/>
                    <measurement group_id="B5" value="44.2" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age at onset of Binge Eating Disorder (BED)</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.7" spread="11.2"/>
                    <measurement group_id="B2" value="25.5" spread="11.1"/>
                    <measurement group_id="B3" value="25.7" spread="15.1"/>
                    <measurement group_id="B4" value="29.1" spread="13.1"/>
                    <measurement group_id="B5" value="26.2" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Binge Eating (Remission)</title>
        <description>Remission from binge eating (zero binge episodes during previous 28 days)</description>
        <time_frame>4 months treatment; 6 and 12 month follow up post treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sibutramine</title>
            <description>Sibutramine 15 mg daily
Sibutramine: 15 mg daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo Daily
Placebo: Daily</description>
          </group>
          <group group_id="O3">
            <title>Placebo/CBTsh</title>
            <description>Placebo and Self-help CBT Placebo daily, Cognitive behavioral self-help manual for binge eating
Self-help CBT + Sibutramine: Cognitive behavioral treatment manual for binge eating Sibutramine 15 mg daily</description>
          </group>
          <group group_id="O4">
            <title>Sibutramine/CBTsh</title>
            <description>Sibutramine and Self-help CBT 15 mg daily Cognitive behavioral treatment manual for binge eating
Self-help CBT + Placebo: Cognitive behavioral treatment manual for binge eating Placebo daily</description>
          </group>
        </group_list>
        <measure>
          <title>Binge Eating (Remission)</title>
          <description>Remission from binge eating (zero binge episodes during previous 28 days)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="25"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Remission at Post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="11.4"/>
                    <measurement group_id="O2" value="8" spread="9.9"/>
                    <measurement group_id="O3" value="6" spread="7.6"/>
                    <measurement group_id="O4" value="6" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at 6 month follow up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at 12 month follow up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Post-treatment</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.60</p_value>
            <method>Chi-squared</method>
            <method_desc>df=3</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>6 month follow up</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>Chi-squared</method>
            <method_desc>df=3</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>12 month follow up</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.29</p_value>
            <method>Chi-squared</method>
            <method_desc>df=3</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>BMI</title>
        <time_frame>4 months treatment</time_frame>
        <population>Participants with complete data reported here (i.e., no imputation)</population>
        <group_list>
          <group group_id="O1">
            <title>Sibutramine</title>
            <description>Sibutramine 15 mg daily
Sibutramine: 15 mg daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo Daily
Placebo: Daily</description>
          </group>
          <group group_id="O3">
            <title>Placebo/CBTsh</title>
            <description>Placebo and Self-help CBT Placebo daily, Cognitive behavioral self-help manual for binge eating
Self-help CBT + Sibutramine: Cognitive behavioral treatment manual for binge eating Sibutramine 15 mg daily</description>
          </group>
          <group group_id="O4">
            <title>Sibutramine/CBTsh</title>
            <description>Sibutramine and Self-help CBT 15 mg daily Cognitive behavioral treatment manual for binge eating
Self-help CBT + Placebo: Cognitive behavioral treatment manual for binge eating Placebo daily</description>
          </group>
        </group_list>
        <measure>
          <title>BMI</title>
          <population>Participants with complete data reported here (i.e., no imputation)</population>
          <units>BMI (kg/m^2)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.4" spread="7.2"/>
                    <measurement group_id="O2" value="39.6" spread="5.7"/>
                    <measurement group_id="O3" value="35.9" spread="5.6"/>
                    <measurement group_id="O4" value="35.6" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sibutramine</title>
          <description>Sibutramine 15 mg daily
Sibutramine: 15 mg daily</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo Daily
Placebo: Daily</description>
        </group>
        <group group_id="E3">
          <title>Placebo/CBTsh</title>
          <description>Placebo and Self-help CBT Placebo daily, Cognitive behavioral self-help manual for binge eating
Self-help CBT + Sibutramine: Cognitive behavioral treatment manual for binge eating Sibutramine 15 mg daily</description>
        </group>
        <group group_id="E4">
          <title>Sibutramine/CBTsh</title>
          <description>Sibutramine and Self-help CBT 15 mg daily Cognitive behavioral treatment manual for binge eating
Self-help CBT + Placebo: Cognitive behavioral treatment manual for binge eating Placebo daily</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Elevated blood pressure</sub_title>
                <description>Patients medically withdrawn due to elevation in blood pressure during treatment (i.e., in excess of 145/90 BP, 100 pulse)</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Carlos Grilo</name_or_title>
      <organization>Yale University School of Medicine</organization>
      <phone>2037852792</phone>
      <email>carlos.grilo@yale.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

